NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · Real-Time Price · USD
2.880
-0.020 (-0.69%)
Oct 22, 2024, 4:00 PM EDT - Market closed
NeuroBo Pharmaceuticals Market Cap
NeuroBo Pharmaceuticals has a market cap or net worth of $24.44 million as of October 23, 2024. Its market cap has increased by 38.09% in one year.
Market Cap
24.44M
Enterprise Value
-3.43M
1-Year Change
38.09%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since August 5, 2016, NeuroBo Pharmaceuticals's market cap has decreased from $84.50M to $24.44M, a decrease of -71.07%. That is a compound annual growth rate of -14.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 21, 2024 | 24.70M | 37.99% |
Dec 29, 2023 | 17.90M | 280.85% |
Dec 30, 2022 | 4.70M | -85.49% |
Dec 31, 2021 | 32.40M | -62.41% |
Dec 31, 2020 | 86.20M | 1,557.69% |
Dec 31, 2019 | 5.20M | -55.17% |
Dec 31, 2018 | 11.60M | -86.27% |
Dec 29, 2017 | 84.50M | 16.23% |
Dec 30, 2016 | 72.70M | -13.96% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ATI Physical Therapy | 26.76M |
Akari Therapeutics, | 26.66M |
The Oncology Institute | 26.55M |
Pluri | 26.42M |
Tonix Pharmaceuticals Holding | 26.40M |
Inspira Technologies Oxy B.H.N. | 25.81M |
CytoMed Therapeutics | 25.62M |
iBio, Inc. | 25.48M |